NIH-funded research R01 grant

Investigating how SAP97 affects brain function and schizophrenia.

Official title: Uncovering the role of SAP97 in synaptic function and schizophrenia.

Funded at University of Southern California · NIH-11087665 · Data updated 2026-11-12

This study is looking at a protein called SAP97 in the brain to see how it affects communication between brain cells, which might help us understand more about schizophrenia and why it happens.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Southern California
NIH-funded
Lab location1 site (Los Angeles, UNITED STATES)
Project startJune 15, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$455,016
NIH project number5R01NS130185-03
Project IDNIH-11087665 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with schizophrenia or those at risk of developing the disorder.

Less likely to help

Patients with other psychiatric disorders unrelated to schizophrenia may not benefit from this research.

What this research studies

This research explores the role of a protein called SAP97 in the brain's synaptic function, particularly in relation to schizophrenia. It aims to understand how disruptions in SAP97 can lead to increased neuronal activity and glutamatergic transmission in the hippocampus, which may contribute to the development of schizophrenia. The study will utilize advanced imaging and electrophysiological techniques to examine the specific functions of SAP97 in regulating neurotransmission and synaptic plasticity. By uncovering these mechanisms, the research seeks to provide insights into the biological underpinnings of schizophrenia.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating schizophrenia by targeting synaptic dysfunction.

How similar studies have gone: Previous research has shown promising results in understanding synaptic mechanisms in schizophrenia, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Southern California
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Herring, Bruce — University of Southern California
  • Study coordinator: Herring, Bruce

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.